Global and Regional Flow Cytometry research

Flow Cytometry Comprehensive Study by Type (Cytometry Platforms (Sorters, Analyzers), Replaceable Components (Filter, Laser, Detectors, Others), Accessories, Reagents and Consumables (Antibodies, Dyes, Beads, Solutions, Buffers, Others), Software, Services), Application (Academic and Clinical Research (Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others), Diagnosis (Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others)), Technology (Cell-Based, Bead-Based), End User (Commercial Organizations, Medical Schools and Clinical Labs, Hospitals, Academics, Others) Players and Region - Global Market Outlook to 2027

Flow Cytometry Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 9.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Flow Cytometry Market Scope?
Growth in the use of flow cytometry in stem cell research will help to boost the global flow cytometry market. Flow cytometry is a method used to identify and measure the physical and chemical features of a population of cells or particles. Additionally, it is used in cell counting, cell sorting, detecting biomarker, and protein engineering. There is a large void in diagnostics accessibility, particularly in the developing regions. So, the growing incidences of HIV AIDS and cancer can be measured a substantial growth opportunity for the global flow cytometry market.

Flow Cytometry Market Dynamics:
AttributesDetails
Growth Drivers
  • Growing Prevalence of Cancer and HIV/AIDS
  • Upsurge in the Applications of Flow Cytometry in Clinical Research
  • Increasing Adoption of Flow Cytometry Techniques in Research and Academia
Influencing Trends
  • The Emergence and Commercial Application of New Technologies in the Field Of Flow Cytometry
  • Intensifying Stem Cell Research
  • Developing Public-Private Initiatives in the Field Of Immunology and Immuno-Oncology Researches
Restraints
  • Lack of Skilled Professionals
  • The Lack of Proper Knowledge
Road Blocks / Challenges
  • Inadequate Research Infrastructure across Emerging Countries
  • Complexities Related To Reagent Development
Gaps & Opportunities
  • Growing Availability of Novel Application-Specific Flow Cytometry Products
  • Increasing Market Presence in Emerging Countries
  • Adoption of Recombinant DNA Technology for Antibody Production


The Flow Cytometry market study is being classified by Type (Cytometry Platforms [Sorters, Analyzers], Replaceable Components [Filter, Laser, Detectors, Others], Accessories, Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others], Software and Services), by Application and major geographies with country level break-up. According to AMA, the Global Flow Cytometry market is expected to see growth rate of 9.3% and may see market size of USD5.9 Billion by 2027.

Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Flow Cytometry market throughout the predicted period.

Becton, Dickinson and Company (United States), Thermo Fisher Scientific, Inc. (United States), Beckman Coulter, Inc. (United States), Merck KGaA (Germany), Luminex Corporation, Sysmex Partec GmbH (Germany), Miltenyi Biotec GmbH (Germany), Agilent Technologies, Inc. (United States), bioMérieux S.A. (France) and Bio-Rad Laboratories, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sony Biotechnology, Inc., Enzo Life Sciences, Inc., Stratedigm, Inc., Cytonome/ST LLC and Apogee Flow Systems Ltd. (United Kingdom).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Flow Cytometry market by Type, Application and Region.

On the basis of geography, the market of Flow Cytometry has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region hold largest market share in the year 2021. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement.

Market Influencers and their Development Strategies
On 26th March 2019, BD (Becton, Dickinson and Company), a leading global medical technology company has announced the CE-IVD certification for the BD FACSDuet™ automated flow cytometry system. It allows clinical laboratories to expand their efficiency by dropping errors and restraining the manual user interactions required to run assays on the BD FACSLyric™ clinical flow cytometer.
On 18th October 2018, Luminex has acquired MilliporeSigma's flow cytometry portfolio. The deal is established for 75 million dollars, consisting of about 69.9 million dollars to be paid under a stock and asset purchase agreement and about 5.1 million dollars in committed inventory purchases.


Key Target Audience
Government Regulatory Bodies, Government and Private Research Organizations and Others

Flow Cytometry Market Study: Important Years
AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Billion)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Flow Cytometry Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Flow Cytometry industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Cytometry Platforms [Sorters, Analyzers]
  • Replaceable Components [Filter, Laser, Detectors, Others]
  • Accessories
  • Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others]
  • Software
  • Services
By Application
  • Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others]
  • Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others]
By Technology
  • Cell-Based
  • Bead-Based

By End User
  • Commercial Organizations
  • Medical Schools and Clinical Labs
  • Hospitals
  • Academics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Cancer and HIV/AIDS
      • 3.2.2. Upsurge in the Applications of Flow Cytometry in Clinical Research
      • 3.2.3. Increasing Adoption of Flow Cytometry Techniques in Research and Academia
    • 3.3. Market Challenges
      • 3.3.1. Inadequate Research Infrastructure across Emerging Countries
      • 3.3.2. Complexities Related To Reagent Development
    • 3.4. Market Trends
      • 3.4.1. The Emergence and Commercial Application of New Technologies in the Field Of Flow Cytometry
      • 3.4.2. Intensifying Stem Cell Research
      • 3.4.3. Developing Public-Private Initiatives in the Field Of Immunology and Immuno-Oncology Researches
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Flow Cytometry, by Type, Application, Technology, End User and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Flow Cytometry (Value)
      • 5.2.1. Global Flow Cytometry by: Type (Value)
        • 5.2.1.1. Cytometry Platforms [Sorters, Analyzers]
        • 5.2.1.2. Replaceable Components [Filter, Laser, Detectors, Others]
        • 5.2.1.3. Accessories
        • 5.2.1.4. Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others]
        • 5.2.1.5. Software
        • 5.2.1.6. Services
      • 5.2.2. Global Flow Cytometry by: Application (Value)
        • 5.2.2.1. Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others]
        • 5.2.2.2. Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others]
      • 5.2.3. Global Flow Cytometry by: Technology (Value)
        • 5.2.3.1. Cell-Based
        • 5.2.3.2. Bead-Based
      • 5.2.4. Global Flow Cytometry by: End User (Value)
        • 5.2.4.1. Commercial Organizations
        • 5.2.4.2. Medical Schools and Clinical Labs
        • 5.2.4.3. Hospitals
        • 5.2.4.4. Academics
        • 5.2.4.5. Others
      • 5.2.5. Global Flow Cytometry Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Flow Cytometry: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Beckman Coulter, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck KGaA (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Luminex Corporation
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sysmex Partec GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Miltenyi Biotec GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Agilent Technologies, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BioMérieux S.A. (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Flow Cytometry Sale, by Type, Application, Technology, End User and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Flow Cytometry (Value)
      • 7.2.1. Global Flow Cytometry by: Type (Value)
        • 7.2.1.1. Cytometry Platforms [Sorters, Analyzers]
        • 7.2.1.2. Replaceable Components [Filter, Laser, Detectors, Others]
        • 7.2.1.3. Accessories
        • 7.2.1.4. Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others]
        • 7.2.1.5. Software
        • 7.2.1.6. Services
      • 7.2.2. Global Flow Cytometry by: Application (Value)
        • 7.2.2.1. Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others]
        • 7.2.2.2. Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others]
      • 7.2.3. Global Flow Cytometry by: Technology (Value)
        • 7.2.3.1. Cell-Based
        • 7.2.3.2. Bead-Based
      • 7.2.4. Global Flow Cytometry by: End User (Value)
        • 7.2.4.1. Commercial Organizations
        • 7.2.4.2. Medical Schools and Clinical Labs
        • 7.2.4.3. Hospitals
        • 7.2.4.4. Academics
        • 7.2.4.5. Others
      • 7.2.5. Global Flow Cytometry Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Flow Cytometry: by Type(USD Billion)
  • Table 2. Flow Cytometry Cytometry Platforms [Sorters, Analyzers] , by Region USD Billion (2016-2021)
  • Table 3. Flow Cytometry Replaceable Components [Filter, Laser, Detectors, Others] , by Region USD Billion (2016-2021)
  • Table 4. Flow Cytometry Accessories , by Region USD Billion (2016-2021)
  • Table 5. Flow Cytometry Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others] , by Region USD Billion (2016-2021)
  • Table 6. Flow Cytometry Software , by Region USD Billion (2016-2021)
  • Table 7. Flow Cytometry Services , by Region USD Billion (2016-2021)
  • Table 8. Flow Cytometry: by Application(USD Billion)
  • Table 9. Flow Cytometry Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others] , by Region USD Billion (2016-2021)
  • Table 10. Flow Cytometry Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others] , by Region USD Billion (2016-2021)
  • Table 11. Flow Cytometry: by Technology(USD Billion)
  • Table 12. Flow Cytometry Cell-Based , by Region USD Billion (2016-2021)
  • Table 13. Flow Cytometry Bead-Based , by Region USD Billion (2016-2021)
  • Table 14. Flow Cytometry: by End User(USD Billion)
  • Table 15. Flow Cytometry Commercial Organizations , by Region USD Billion (2016-2021)
  • Table 16. Flow Cytometry Medical Schools and Clinical Labs , by Region USD Billion (2016-2021)
  • Table 17. Flow Cytometry Hospitals , by Region USD Billion (2016-2021)
  • Table 18. Flow Cytometry Academics , by Region USD Billion (2016-2021)
  • Table 19. Flow Cytometry Others , by Region USD Billion (2016-2021)
  • Table 20. South America Flow Cytometry, by Country USD Billion (2016-2021)
  • Table 21. South America Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 22. South America Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 23. South America Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 24. South America Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 25. Brazil Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 26. Brazil Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 27. Brazil Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 28. Brazil Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 29. Argentina Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 30. Argentina Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 31. Argentina Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 32. Argentina Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 33. Rest of South America Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 34. Rest of South America Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 35. Rest of South America Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 36. Rest of South America Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 37. Asia Pacific Flow Cytometry, by Country USD Billion (2016-2021)
  • Table 38. Asia Pacific Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 39. Asia Pacific Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 40. Asia Pacific Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 41. Asia Pacific Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 42. China Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 43. China Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 44. China Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 45. China Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 46. Japan Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 47. Japan Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 48. Japan Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 49. Japan Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 50. India Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 51. India Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 52. India Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 53. India Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 54. South Korea Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 55. South Korea Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 56. South Korea Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 57. South Korea Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 58. Taiwan Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 59. Taiwan Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 60. Taiwan Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 61. Taiwan Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 62. Australia Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 63. Australia Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 64. Australia Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 65. Australia Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 66. Rest of Asia-Pacific Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 67. Rest of Asia-Pacific Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 68. Rest of Asia-Pacific Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 69. Rest of Asia-Pacific Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 70. Europe Flow Cytometry, by Country USD Billion (2016-2021)
  • Table 71. Europe Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 72. Europe Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 73. Europe Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 74. Europe Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 75. Germany Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 76. Germany Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 77. Germany Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 78. Germany Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 79. France Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 80. France Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 81. France Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 82. France Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 83. Italy Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 84. Italy Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 85. Italy Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 86. Italy Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 87. United Kingdom Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 88. United Kingdom Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 89. United Kingdom Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 90. United Kingdom Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 91. Netherlands Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 92. Netherlands Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 93. Netherlands Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 94. Netherlands Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 95. Rest of Europe Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 96. Rest of Europe Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 97. Rest of Europe Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 98. Rest of Europe Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 99. MEA Flow Cytometry, by Country USD Billion (2016-2021)
  • Table 100. MEA Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 101. MEA Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 102. MEA Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 103. MEA Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 104. Middle East Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 105. Middle East Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 106. Middle East Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 107. Middle East Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 108. Africa Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 109. Africa Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 110. Africa Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 111. Africa Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 112. North America Flow Cytometry, by Country USD Billion (2016-2021)
  • Table 113. North America Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 114. North America Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 115. North America Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 116. North America Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 117. United States Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 118. United States Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 119. United States Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 120. United States Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 121. Canada Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 122. Canada Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 123. Canada Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 124. Canada Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 125. Mexico Flow Cytometry, by Type USD Billion (2016-2021)
  • Table 126. Mexico Flow Cytometry, by Application USD Billion (2016-2021)
  • Table 127. Mexico Flow Cytometry, by Technology USD Billion (2016-2021)
  • Table 128. Mexico Flow Cytometry, by End User USD Billion (2016-2021)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Flow Cytometry: by Type(USD Billion)
  • Table 140. Flow Cytometry Cytometry Platforms [Sorters, Analyzers] , by Region USD Billion (2022-2027)
  • Table 141. Flow Cytometry Replaceable Components [Filter, Laser, Detectors, Others] , by Region USD Billion (2022-2027)
  • Table 142. Flow Cytometry Accessories , by Region USD Billion (2022-2027)
  • Table 143. Flow Cytometry Reagents and Consumables [Antibodies, Dyes, Beads, Solutions, Buffers, Others] , by Region USD Billion (2022-2027)
  • Table 144. Flow Cytometry Software , by Region USD Billion (2022-2027)
  • Table 145. Flow Cytometry Services , by Region USD Billion (2022-2027)
  • Table 146. Flow Cytometry: by Application(USD Billion)
  • Table 147. Flow Cytometry Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others] , by Region USD Billion (2022-2027)
  • Table 148. Flow Cytometry Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others] , by Region USD Billion (2022-2027)
  • Table 149. Flow Cytometry: by Technology(USD Billion)
  • Table 150. Flow Cytometry Cell-Based , by Region USD Billion (2022-2027)
  • Table 151. Flow Cytometry Bead-Based , by Region USD Billion (2022-2027)
  • Table 152. Flow Cytometry: by End User(USD Billion)
  • Table 153. Flow Cytometry Commercial Organizations , by Region USD Billion (2022-2027)
  • Table 154. Flow Cytometry Medical Schools and Clinical Labs , by Region USD Billion (2022-2027)
  • Table 155. Flow Cytometry Hospitals , by Region USD Billion (2022-2027)
  • Table 156. Flow Cytometry Academics , by Region USD Billion (2022-2027)
  • Table 157. Flow Cytometry Others , by Region USD Billion (2022-2027)
  • Table 158. South America Flow Cytometry, by Country USD Billion (2022-2027)
  • Table 159. South America Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 160. South America Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 161. South America Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 162. South America Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 163. Brazil Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 164. Brazil Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 165. Brazil Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 166. Brazil Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 167. Argentina Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 168. Argentina Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 169. Argentina Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 170. Argentina Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 171. Rest of South America Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 172. Rest of South America Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 173. Rest of South America Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 174. Rest of South America Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 175. Asia Pacific Flow Cytometry, by Country USD Billion (2022-2027)
  • Table 176. Asia Pacific Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 177. Asia Pacific Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 178. Asia Pacific Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 179. Asia Pacific Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 180. China Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 181. China Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 182. China Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 183. China Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 184. Japan Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 185. Japan Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 186. Japan Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 187. Japan Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 188. India Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 189. India Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 190. India Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 191. India Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 192. South Korea Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 193. South Korea Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 194. South Korea Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 195. South Korea Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 196. Taiwan Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 197. Taiwan Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 198. Taiwan Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 199. Taiwan Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 200. Australia Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 201. Australia Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 202. Australia Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 203. Australia Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 204. Rest of Asia-Pacific Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 205. Rest of Asia-Pacific Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 206. Rest of Asia-Pacific Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 207. Rest of Asia-Pacific Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 208. Europe Flow Cytometry, by Country USD Billion (2022-2027)
  • Table 209. Europe Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 210. Europe Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 211. Europe Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 212. Europe Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 213. Germany Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 214. Germany Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 215. Germany Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 216. Germany Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 217. France Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 218. France Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 219. France Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 220. France Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 221. Italy Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 222. Italy Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 223. Italy Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 224. Italy Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 225. United Kingdom Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 226. United Kingdom Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 227. United Kingdom Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 228. United Kingdom Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 229. Netherlands Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 230. Netherlands Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 231. Netherlands Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 232. Netherlands Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 233. Rest of Europe Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 234. Rest of Europe Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 235. Rest of Europe Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 236. Rest of Europe Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 237. MEA Flow Cytometry, by Country USD Billion (2022-2027)
  • Table 238. MEA Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 239. MEA Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 240. MEA Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 241. MEA Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 242. Middle East Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 243. Middle East Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 244. Middle East Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 245. Middle East Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 246. Africa Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 247. Africa Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 248. Africa Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 249. Africa Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 250. North America Flow Cytometry, by Country USD Billion (2022-2027)
  • Table 251. North America Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 252. North America Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 253. North America Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 254. North America Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 255. United States Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 256. United States Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 257. United States Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 258. United States Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 259. Canada Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 260. Canada Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 261. Canada Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 262. Canada Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 263. Mexico Flow Cytometry, by Type USD Billion (2022-2027)
  • Table 264. Mexico Flow Cytometry, by Application USD Billion (2022-2027)
  • Table 265. Mexico Flow Cytometry, by Technology USD Billion (2022-2027)
  • Table 266. Mexico Flow Cytometry, by End User USD Billion (2022-2027)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Flow Cytometry: by Type USD Billion (2016-2021)
  • Figure 5. Global Flow Cytometry: by Application USD Billion (2016-2021)
  • Figure 6. Global Flow Cytometry: by Technology USD Billion (2016-2021)
  • Figure 7. Global Flow Cytometry: by End User USD Billion (2016-2021)
  • Figure 8. South America Flow Cytometry Share (%), by Country
  • Figure 9. Asia Pacific Flow Cytometry Share (%), by Country
  • Figure 10. Europe Flow Cytometry Share (%), by Country
  • Figure 11. MEA Flow Cytometry Share (%), by Country
  • Figure 12. North America Flow Cytometry Share (%), by Country
  • Figure 13. Global Flow Cytometry share by Players 2021 (%)
  • Figure 14. Global Flow Cytometry share by Players (Top 3) 2021(%)
  • Figure 15. Global Flow Cytometry share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. Becton, Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 19. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2021
  • Figure 21. Beckman Coulter, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Beckman Coulter, Inc. (United States) Revenue: by Geography 2021
  • Figure 23. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Merck KGaA (Germany) Revenue: by Geography 2021
  • Figure 25. Luminex Corporation Revenue, Net Income and Gross profit
  • Figure 26. Luminex Corporation Revenue: by Geography 2021
  • Figure 27. Sysmex Partec GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Sysmex Partec GmbH (Germany) Revenue: by Geography 2021
  • Figure 29. Miltenyi Biotec GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Miltenyi Biotec GmbH (Germany) Revenue: by Geography 2021
  • Figure 31. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Agilent Technologies, Inc. (United States) Revenue: by Geography 2021
  • Figure 33. BioMérieux S.A. (France) Revenue, Net Income and Gross profit
  • Figure 34. BioMérieux S.A. (France) Revenue: by Geography 2021
  • Figure 35. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2021
  • Figure 37. Global Flow Cytometry: by Type USD Billion (2022-2027)
  • Figure 38. Global Flow Cytometry: by Application USD Billion (2022-2027)
  • Figure 39. Global Flow Cytometry: by Technology USD Billion (2022-2027)
  • Figure 40. Global Flow Cytometry: by End User USD Billion (2022-2027)
  • Figure 41. South America Flow Cytometry Share (%), by Country
  • Figure 42. Asia Pacific Flow Cytometry Share (%), by Country
  • Figure 43. Europe Flow Cytometry Share (%), by Country
  • Figure 44. MEA Flow Cytometry Share (%), by Country
  • Figure 45. North America Flow Cytometry Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson and Company (United States)
  • Thermo Fisher Scientific, Inc. (United States)
  • Beckman Coulter, Inc. (United States)
  • Merck KGaA (Germany)
  • Luminex Corporation
  • Sysmex Partec GmbH (Germany)
  • Miltenyi Biotec GmbH (Germany)
  • Agilent Technologies, Inc. (United States)
  • bioMérieux S.A. (France)
  • Bio-Rad Laboratories, Inc. (United States)
Additional players considered in the study are as follows:
Sony Biotechnology, Inc. , Enzo Life Sciences, Inc. , Stratedigm, Inc. , Cytonome/ST LLC , Apogee Flow Systems Ltd. (United Kingdom)
Select User Access Type

Key Highlights of Report


Aug 2022 125 Pages 65 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global and Regional Flow Cytometry research Quantitative research analysis
Global and Regional Flow Cytometry research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Flow Cytometry market are Becton, Dickinson and Company (United States), Thermo Fisher Scientific, Inc. (United States), Beckman Coulter, Inc. (United States), Merck KGaA (Germany), Luminex Corporation, Sysmex Partec GmbH (Germany), Miltenyi Biotec GmbH (Germany), Agilent Technologies, Inc. (United States), bioMérieux S.A. (France) and Bio-Rad Laboratories, Inc. (United States).
In this highly competitive & fast evolving Flow Cytometry industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Academic and Clinical Research [Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others] and Diagnosis [Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others] are the potential customers of Flow Cytometry industry.
The Global Flow Cytometry market is expected to see a growth of 9.3% during projected year 2021 to 2027.
As per AMA Research, the Global Flow Cytometry market is seen at a value of USD3.9 Billion.

Know More About Global and Regional Flow Cytometry research Report?

Have a Query? Click Here

Other Related Reports

Microarray Comprehensive Study by Type (DNA Microarray, Oligonucleotide Microarray, Protein Microarray, Tissue Microarray), Application (Gene expression, Disease diagnosis and development), End Use (...
$ 3350
Patient Simulator Comprehensive Study by Type (Childbirth Simulator, Adult Patient Simulator, Infant Simulator, Others), Application (Training, Education), Training Services (Vendor-based Training, C...
$ 3750
Artificial Knee Joint Comprehensive Study by Application (Hospitals, Specialized Orthopedic Clinics, Ambulatory Surgical Centers), Material (Stainless Steel, Cobalt-chromium Alloys, Titanium and Tita...
$ 3350
Array Instruments Comprehensive Study by Type (DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays, Others), Application (Gene Expression, Genotyping, Whole Genome Cytogene...
$ 3750
Clinical Intelligence Comprehensive Study by Application (Medical Imaging & Diagnostics, Patient Data and Risk Analysis, Inpatient Care & Hospital Management, Lifestyle Management & Monitoring, Virtu...
$ 3450
Video Telemedicine Comprehensive Study by Application (Cardiology, Orthopedics, Radiology, Neurology, Dermatology, Gynecology, Dentistry, Oncology, Pathology), Communication Technologies (3G (GSM, CD...
$ 3750